AI avatars support lung cancer patients in Chelsea
Patients undergoing tests for suspected lung cancer at Chelsea and Westminster Hospital can now get multilingual information and personalised guidance from a new AI-powered platform launched during Lung Cancer Awareness Month.
The Lung Cancer Digital Avatar Project, powered by OcciAI, was developed by trust clinicians to help patients understand the tests, scans and appointments involved in investigating suspected lung cancer. It features short videos using AI-powered digital avatars representing members of the lung cancer multidisciplinary team, explaining each test, why it is needed and what to expect at the appointment.
Information in ten languages
The platform also offers written information, animations and an AI-supported question-and-answer function in the patient’s preferred language, drawing on trusted clinical resources. Information is available in English and will initially be rolled out in the ten most translated languages, aiming to reduce language barriers and support people with different levels of health literacy.
Dr Orhan Orhan, consultant respiratory physician and clinical lead for the project, pointed to the anxiety patients can experience between being referred for suspected lung cancer and getting answers, and said the platform was designed to support them through that diagnostic journey.
From pilot to standard practice
The technology follows a 2025 pilot funded by the trust’s charity CW+ and the Friends of Chelsea and Westminster Hospital, and has now become part of standard practice. The project was supported by CW Innovation, the trust’s joint innovation programme with CW+, and funded by MSD. The team worked with the Roy Castle Lung Cancer Foundation, with feedback from patient advocates and people with lived experience. The platform is being rolled out to patients on the suspected cancer pathway, with the hope that the approach could be adapted for other cancer pathways and healthcare services in future.